BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23671016)

  • 1. Insight in Alzheimer's disease and its relation to psychiatric and behavioral disturbances.
    Horning SM; Melrose R; Sultzer D
    Int J Geriatr Psychiatry; 2014 Jan; 29(1):77-84. PubMed ID: 23671016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndromic validity of apathy in Alzheimer's disease.
    Starkstein SE; Petracca G; Chemerinski E; Kremer J
    Am J Psychiatry; 2001 Jun; 158(6):872-7. PubMed ID: 11384893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].
    Derouesné C; Lacomblez L; Fiori N; Gély-Nargeot MC; Bungener C
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):107-15. PubMed ID: 22414405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment.
    Jacus JP
    Brain Behav; 2017 Apr; 7(4):e00661. PubMed ID: 28413709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.
    Robert PH; Clairet S; Benoit M; Koutaich J; Bertogliati C; Tible O; Caci H; Borg M; Brocker P; Bedoucha P
    Int J Geriatr Psychiatry; 2002 Dec; 17(12):1099-105. PubMed ID: 12461757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical associations of anosognosia in mild cognitive impairment and Alzheimer's disease.
    Mak E; Chin R; Ng LT; Yeo D; Hameed S
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1207-14. PubMed ID: 25754519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Social Cognition Measurements Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Apathy?
    Mariano LI; Caramelli P; Guimarães HC; Gambogi LB; Moura MVB; Yassuda MS; Teixeira AL; de Souza LC
    J Alzheimers Dis; 2020; 74(3):817-827. PubMed ID: 32116247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale.
    Sultzer DL; Levin HS; Mahler ME; High WM; Cummings JL
    J Am Geriatr Soc; 1992 Jun; 40(6):549-55. PubMed ID: 1587970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facial expression in Alzheimer's disease: impact of cognitive deficits and neuropsychiatric symptoms.
    Seidl U; Lueken U; Thomann PA; Kruse A; Schröder J
    Am J Alzheimers Dis Other Demen; 2012 Mar; 27(2):100-6. PubMed ID: 22495337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects.
    Richard E; Schmand B; Eikelenboom P; Yang SC; Ligthart SA; Moll van Charante EP; van Gool WA;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):204-9. PubMed ID: 22722671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between behavioral syndromes and cognitive domains in Alzheimer disease: the impact of mood and psychosis.
    Koppel J; Goldberg TE; Gordon ML; Huey E; Davies P; Keehlisen L; Huet S; Christen E; Greenwald BS
    Am J Geriatr Psychiatry; 2012 Nov; 20(11):994-1000. PubMed ID: 22048323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G; Baldinetti F; Buccione I; Fadda L; Perri R; Scalmana S; Serra L; Caltagirone C
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closing-in is related to apathy in Alzheimer's disease patients.
    Grossi D; de Lucia N; Trojano L
    J Alzheimers Dis; 2015; 43(3):849-55. PubMed ID: 25125462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Graff-Guerrero A; Mimura M; Nakayama K
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1264-1271. PubMed ID: 27714849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of neuropsychiatric syndromes with global clinical deterioration in Alzheimer's disease patients.
    Stella F; Laks J; Govone JS; de Medeiros K; Forlenza OV
    Int Psychogeriatr; 2016 May; 28(5):779-86. PubMed ID: 26673910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Noncognitive symptoms in Alzheimer's disease. A study of 150 community-dwelling patients using a questionnaire completed by the caregiver].
    Derouesné C; Piquard A; Thibault S; Baudouin-Madec V; Lacomblez L
    Rev Neurol (Paris); 2001 Feb; 157(2):162-77. PubMed ID: 11283463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease.
    Radakovic R; Starr JM; Abrahams S
    J Alzheimers Dis; 2017; 60(1):57-67. PubMed ID: 28759970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apathy predicts more severe parkinsonism in Alzheimer's disease.
    Starkstein SE; Merello M; Brockman S; Bruce D; Petracca G; Power BD
    Am J Geriatr Psychiatry; 2009 Apr; 17(4):291-8. PubMed ID: 19322935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.